This chapter follows the supplied KMU learning outcomes and builds the topic in a logical sequence. First understand how histamine and serotonin drugs work, then connect these principles with antidotes and the general management of poisoning. Use the final high-yield review only after understanding the main explanations.
Topic 5 — Histamine and Serotonin Pharmacology, Antidotes and General Management of Poisoning
Infection and Inflammation
Topic Introduction
Histamine and serotonin are important chemical mediators that influence several organ systems. Drugs that block or mimic their actions are widely used in clinical medicine. In this chapter, you will learn how H1-receptor antagonists are classified, how first- and second-generation antihistamines differ, and how their receptor blockade produces therapeutic and adverse effects. You will also study important serotonin agonists and antagonists, including the basis for using ondansetron in chemotherapy-induced vomiting. The final part introduces antidotes and the general principles used to manage a poisoned patient. The emphasis throughout is on understanding how a drug’s mechanism leads to its clinical effect. :contentReference[oaicite:0]{index=0}
A. Antihistamines: Classification and Basic Principles
Antihistamines are drugs that reduce the effects of histamine by acting mainly at histamine receptors. In the context of common allergic disorders, the most important drugs are H1-receptor antagonists. They do not usually prevent histamine from being released. Instead, they reduce the ability of histamine to produce its effects at H1 receptors.
Clinically useful H1 antihistamines are commonly divided into first-generation and second-generation drugs. This classification is especially important because the two groups differ in their ability to enter the central nervous system and therefore in their tendency to produce sedation.
Classification of H1-receptor antagonists
First-generation H1 antihistamines are relatively lipid soluble and readily cross the blood-brain barrier. Important examples include:
- Diphenhydramine
- Chlorpheniramine
- Promethazine
- Dimenhydrinate
- Hydroxyzine
- Meclizine
Second-generation H1 antihistamines enter the brain much less readily and therefore cause much less sedation at usual therapeutic doses. Important examples include:
- Cetirizine
- Levocetirizine
- Loratadine
- Desloratadine
- Fexofenadine
| Feature | First generation | Second generation |
|---|---|---|
| Blood-brain barrier penetration | Marked | Limited |
| Sedation | Common | Much less common |
| Antimuscarinic effects | More prominent | Minimal in most drugs |
| Preferred for routine daytime allergy treatment | Usually less suitable | Usually preferred |
B. H1-Receptor Antagonists: Mechanism and Pharmacological Effects
Histamine acting at H1 receptors contributes to many features of immediate allergic responses. It promotes vasodilation, increases vascular permeability, stimulates sensory nerve endings and contributes to bronchial smooth-muscle contraction. H1 antihistamines reduce these effects by preventing effective H1-receptor activation.
H1 antihistamine
→ blocks functional H1-receptor activation
→ reduces histamine-mediated vascular and sensory effects
→ decreases itching, erythema, edema and other allergic symptoms.
Major pharmacological effects
Reduction of vascular effects: Histamine increases permeability of small blood vessels, allowing plasma fluid to enter tissues and produce edema. H1 blockade reduces this response and therefore decreases wheal formation and tissue swelling.
Reduction of itching: Histamine stimulates sensory nerve endings. Blocking H1 receptors therefore reduces pruritus associated with many allergic conditions.
Reduction of histamine-mediated smooth-muscle effects: H1 antagonists reduce histamine-induced contraction of certain smooth muscles, including bronchial smooth muscle. However, they are not the main treatment for acute severe bronchospasm.
Central nervous system effects: First-generation drugs enter the CNS and frequently produce sedation. Some also have antiemetic or antimotion-sickness actions because they affect central histaminergic and other receptor systems.
Antimuscarinic effects: Several first-generation H1 antagonists also block muscarinic receptors. This explains adverse effects such as dry mouth, blurred vision, constipation and urinary retention.
C. Clinical Uses, Adverse Effects and Drug Interactions of H1 Antihistamines
The usefulness of H1 antihistamines depends on whether the patient’s symptoms are substantially mediated by histamine. They are therefore most effective for conditions such as allergic rhinitis and urticaria. The choice between first- and second-generation drugs is influenced mainly by the need to avoid sedation and anticholinergic effects.
Clinical uses
- Allergic rhinitis: reduces sneezing, itching and rhinorrhea.
- Urticaria: reduces wheals and pruritus caused by histamine.
- Other allergic symptoms: useful where H1-mediated itching and edema are prominent.
- Motion sickness: some first-generation agents such as dimenhydrinate and meclizine are useful because of their central actions.
- Nausea and vomiting: selected first-generation agents, particularly promethazine, may be useful in appropriate situations.
In a serious systemic allergic reaction such as anaphylaxis, H1 antihistamines may reduce some cutaneous symptoms but do not replace the primary emergency treatment.
Adverse effects
The adverse-effect pattern is most marked with first-generation drugs because they enter the brain and also interact with other receptors.
- Sedation and impaired alertness: due to central H1 blockade.
- Dry mouth: related mainly to antimuscarinic action.
- Blurred vision: can occur because of antimuscarinic effects on accommodation.
- Constipation: may result from reduced gastrointestinal cholinergic activity.
- Urinary retention: may occur in susceptible individuals because muscarinic blockade reduces bladder contraction.
Important drug interactions
First-generation H1 antihistamines can produce additive CNS depression when combined with other sedating drugs. Their sedative effect may therefore become more marked when taken with agents that also impair alertness. Drugs with antimuscarinic actions may similarly increase anticholinergic adverse effects when given together.
D. Serotonin: Mechanism and Organ-System Effects
Serotonin, also called 5-hydroxytryptamine or 5-HT, is an important neurotransmitter and local mediator. Its effects vary according to the receptor subtype and the tissue in which that receptor is located. Understanding serotonin pharmacology therefore requires linking each clinical effect to receptor activation rather than thinking of serotonin as producing one uniform action throughout the body.
Serotonin acts through several receptor families. Most serotonin receptors are G-protein-coupled receptors, while the 5-HT3 receptor is a ligand-gated ion channel. This difference is important because several clinically useful drugs selectively target particular serotonin receptor subtypes.
Important organ-system effects
Gastrointestinal tract: Serotonin is important in gastrointestinal sensory signaling and motility. Activation of 5-HT3 receptors on vagal afferent pathways is particularly important in the vomiting reflex.
Central nervous system: Serotonergic pathways influence several CNS functions. Pharmacological manipulation of specific serotonin receptors can therefore produce effects on nausea, vascular headache pathways and other functions.
Blood vessels: Serotonin may influence vascular tone. The final response varies with receptor subtype, vascular bed and physiological conditions.
Platelets: Serotonin released in association with platelet activation can contribute to vascular and platelet-related local responses.
→ activates a specific 5-HT receptor subtype
→ alters neuronal, vascular or gastrointestinal signaling
→ produces an organ-specific physiological effect.
E. Serotonin Agonists and Antagonists
Serotonin drugs are classified according to whether they stimulate or block particular 5-HT receptor subtypes. Their clinical effects depend strongly on receptor selectivity. The same transmitter system can therefore be manipulated in different directions for different therapeutic purposes.
Serotonin agonists
Important serotonin-receptor agonists include:
- Sumatriptan and related triptans: agonists mainly at 5-HT1B/1D receptors and used in migraine.
- Buspirone: has partial agonist activity at 5-HT1A receptors.
The principle to remember is that a serotonin agonist does not simply reproduce every action of serotonin. Its clinical action depends on the particular receptor subtype that it activates.
Serotonin antagonists
Serotonin antagonists can also be grouped according to the receptor they block. Important examples include:
- 5-HT3 antagonists: ondansetron and related agents.
- Drugs with 5-HT2-blocking activity: cyproheptadine is an important undergraduate example.
Blocking a particular receptor interrupts the physiological pathway mediated by that receptor. This receptor-based understanding is more useful than memorizing drug names in isolation.
F. Ondansetron and Chemotherapy-Induced Vomiting
Ondansetron is a selective 5-HT3-receptor antagonist. Its importance in chemotherapy-induced vomiting is best understood by following the vomiting pathway from the gastrointestinal tract to the brain.
Certain chemotherapeutic agents can stimulate serotonin release from enterochromaffin cells in the intestinal mucosa. The released serotonin activates 5-HT3 receptors on vagal afferent nerve endings. These sensory signals travel toward central vomiting pathways and contribute strongly to nausea and vomiting.
→ serotonin release from gastrointestinal enterochromaffin cells
→ activation of 5-HT3 receptors on vagal afferents
→ stimulation of central vomiting pathways
→ nausea and vomiting.
Ondansetron blocks 5-HT3 receptors and interrupts this signaling pathway. As a result, the emetic signal reaching the central nervous system is reduced. This explains the pharmacological basis for its use in chemotherapy-induced nausea and vomiting.
G. Antidotes: Definition, Classification and Mechanisms
An antidote is an agent used to reduce or counteract the harmful effects of a poison. Antidotes do not all work in the same way. Some physically prevent absorption, some react chemically with a poison, and others oppose the poison’s effect at a receptor or physiological system. Understanding this classification makes it easier to understand why a particular antidote is useful.
Classification of antidotes
1. Physical or mechanical antidotes
These reduce exposure to a poison mainly by adsorption or physical interference with its absorption. Their action does not depend on receptor antagonism.
2. Chemical antidotes
These interact chemically with the poison or alter it into a less harmful form. Some agents may bind toxic substances and facilitate their removal.
3. Physiological or pharmacological antidotes
These oppose the toxic action of a poison by acting on a receptor or physiological pathway. The antagonist may block the same receptor targeted by the poison or produce an opposing physiological effect.
Examples of antidotal mechanisms
- Receptor antagonism: an antidote blocks the receptor responsible for toxic effects.
- Enzyme reactivation or biochemical reversal: the antidote restores a function impaired by the poison.
- Chelation or binding: the antidote binds a toxic substance and reduces its ability to damage tissues.
- Functional physiological antagonism: the antidote produces a physiological effect that opposes the poisoning effect.
The term antidote should not create the impression that poisoning can always be reversed by giving a specific drug. In many poisonings, supportive care and stabilization remain more important than any specific antidote.
H. General Management of a Case of Poisoning
The management of poisoning is based on priorities rather than on immediately identifying a specific antidote. The first responsibility is to stabilize the patient and prevent immediate threats to life. Once the patient is stable, the clinician assesses the likely poison, limits further exposure where appropriate, provides supportive treatment and uses a specific antidote when indicated.
1. Immediate stabilization
Begin with assessment and support of vital functions. Airway patency, adequate breathing and circulation take priority because severe poisoning may rapidly cause respiratory failure, shock, arrhythmia or impaired consciousness.
- Assess and protect the airway.
- Assess breathing and provide respiratory support when required.
- Assess circulation and treat hemodynamic instability.
- Assess level of consciousness and neurological status.
2. Stop further exposure
If exposure is continuing, remove the patient from the source when this can be done safely. Contaminated clothing or external contamination may require appropriate removal or decontamination. The exact method depends on the route and nature of exposure.
3. Obtain a focused history and examination
The clinician should determine, where possible, what substance was involved, the likely route of exposure, approximate time of exposure, circumstances of poisoning and relevant symptoms. Containers, labels or information from relatives may provide useful clues. Physical examination may reveal a recognizable pattern of toxic effects, but individual findings should be interpreted cautiously.
4. Reduce absorption when appropriate
Measures intended to reduce gastrointestinal absorption are considered only when appropriate for the poison and clinical situation. They must never take priority over airway protection and stabilization. No single decontamination procedure is suitable for every poisoning.
5. Supportive and symptomatic treatment
Many poisoned patients recover mainly because vital physiological functions are supported while the toxin is metabolized or eliminated. Treatment may therefore involve management of respiratory depression, seizures, circulatory disturbance, temperature abnormalities or other major toxic effects according to the patient’s condition.
6. Specific antidote when indicated
If the poison is known or strongly suspected and a suitable antidote exists, the antidote may be administered as part of treatment. The antidote should complement rather than replace resuscitation and supportive care.
7. Enhance elimination in selected cases
For some poisons, specific methods can increase removal from the body. These approaches are not routinely required for every poisoned patient and depend on the toxic substance and the clinical situation.
8. Observation and reassessment
Poisoning may evolve over time. Continued monitoring is therefore important because deterioration, delayed toxicity or complications can develop after the initial assessment.
Integrated Mechanism Flow
↓
Interaction with a receptor, enzyme or physiological pathway
↓
Altered cellular or organ function
↓
Clinical manifestation
↓
Pharmacological intervention blocks, reverses or opposes the mechanism
↓
Reduced symptoms or toxicity
Important Comparison: First- vs Second-Generation H1 Antihistamines
| Feature | First generation | Second generation |
|---|---|---|
| CNS penetration | High | Low |
| Sedation | Prominent | Minimal or less prominent |
| Antimuscarinic effects | Commoner | Usually minimal |
| Routine allergy treatment | Effective but sedation may limit use | Often preferred |
| Motion sickness | Some agents useful | Generally not useful for this purpose |
⭐ AIM High-Yield Review
- H1 antihistamines reduce histamine-mediated allergic symptoms by blocking functional H1-receptor activation.
- First-generation antihistamines readily enter the CNS and commonly cause sedation.
- Second-generation antihistamines have less CNS penetration and are usually less sedating.
- Many first-generation H1 blockers also have antimuscarinic effects, explaining dry mouth, blurred vision, constipation and urinary retention.
- H1 antihistamines are particularly useful for allergic rhinitis, urticaria and pruritus.
- Some first-generation drugs are useful for motion sickness because of their central actions.
- ⭐ Sedating antihistamines can produce additive CNS depression with other CNS depressant drugs.
- Serotonin acts through several 5-HT receptor subtypes; its effect depends on the receptor and tissue involved.
- 5-HT3 receptors participate importantly in the vomiting pathway.
- Ondansetron is a 5-HT3 antagonist and interrupts serotonin-mediated emetic signaling during chemotherapy.
- Serotonin agonists include triptans acting mainly at 5-HT1B/1D receptors.
- Antidotes may act physically, chemically or pharmacologically.
- ⭐ An antidote does not replace stabilization and supportive care in a poisoned patient.
- In poisoning, airway, breathing and circulation are addressed before detailed toxicological diagnosis.
- General poisoning management proceeds from stabilization to exposure control, assessment, appropriate decontamination, supportive care, specific antidote when indicated and continued reassessment.
🎥 Video 1 — H1 Antihistamines: Receptors, First- and Second-Generation Drugs
Use this video to reinforce H1-receptor pharmacology, classification of antihistamines and the major differences between first- and second-generation drugs.
🎥 Video 2 — General Management of Poisoning
Use this video to consolidate the general approach to poisoning, including initial stabilization, assessment, decontamination, supportive treatment and specific management.